“Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c”, Swiss Med Wkly, vol. 133, no. 3334, pp. 455–460, Aug. 2003, doi: 10.4414/smw.2003.10300.